FDA Inspection
Glenmark Pharmaceuticals LimitedGlenmark Pharmaceuticals Limited – FDA Inspection, Jul 19, 2013
Record Details
This FDA Inspection record concerns Glenmark Pharmaceuticals Limited, with an inspection on July 19, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 19, 2013
- Product Type
- Drugs
View Company Profile
ID · d3bf1a09-8a2e-4b48-a074-e7143a83a5d1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 849889
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.80(a)Written Procedures Not Followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Glenmark Pharmaceuticals Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 20, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| March 15, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2017 | Not classified | Office of Inspections and Investigations | |
| May 30, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Glenmark Pharmaceuticals Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.